ABSCIENCES (EPA:AB) AB Science will host a live webcast on indolent systemic mastocytosis on November 20, 2019

Retour

Directive transparence : information réglementée

04/11/2019 19:27

08/01/2020 19:14

AB Science announces that FDA green-lights U.S. patient enrollment in...

02/12/2019 22:31

AB Science provides the summary of webcast with Key Opinion Leaders on...

27/11/2019 08:34

AB Science will host a live webcast on masitinib in severe asthma on...

26/11/2019 19:15

AB Science will host a live webcast on masitinib in severe asthma on...

25/11/2019 08:21

AB Science provides the summary of webcast with Key Opinion Leaders on...

07/11/2019 20:29

AB Science announces positive top-line Phase 3 results for oral masitinib...

06/11/2019 22:21

AB Science announces the first presentation of preclinical results for...

06/11/2019 08:23

AB Science has signed a financing agreement in order to pre-finance the...

04/11/2019 19:27

AB Science will host a live webcast on indolent systemic mastocytosis on...

10/10/2019 08:03

AB Science provides update on masitinib programs timelines

Voir tous les communiqués de ABSCIENCES